Roger D. Dansey

2021

In 2021, Roger D. Dansey earned a total compensation of $8.9M as Chief Medical Officer at Seattle Genetics, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$756,325
Option Awards$2,692,014
Salary$754,614
Stock Awards$4,640,041
Other$18,146
Total$8,861,140

Dansey received $4.6M in stock awards, accounting for 52% of the total pay in 2021.

Dansey also received $756.3K in non-equity incentive plan, $2.7M in option awards, $754.6K in salary and $18.1K in other compensation.

Rankings

In 2021, Roger D. Dansey's compensation ranked 1,247th out of 12,412 executives tracked by ExecPay. In other words, Dansey earned more than 90.0% of executives.

ClassificationRankingPercentile
All
1,247
out of 12,412
90th
Division
Manufacturing
444
out of 5,498
92nd
Major group
Chemicals And Allied Products
161
out of 2,374
93rd
Industry group
Drugs
133
out of 2,095
94th
Industry
Biological Products, Except Diagnostic Substances
39
out of 452
91st

Pay ratio

Roger D. Dansey's Pay$8,861,140
Median Employee's Pay$250,158
Pay Ratio

35

to 1

In 2021, the annual total compensation of Roger D. Dansey was $8,861,140.

The annual total compensation of the median employee at Seattle Genetics was $250,158.

The ratio of Roger D. Dansey's pay to the pay of median employee was therefore 35 to one.

Source: SEC filing on March 30, 2022.

Dansey's colleagues

We found four more compensation records of executives who worked with Roger D. Dansey at Seattle Genetics in 2021.

2021

Clay Siegall

Seattle Genetics

Chief Executive Officer

2021

Todd Simpson

Seattle Genetics

Chief Financial Officer

2021

Chip Romp

Seattle Genetics

Executive Vice President, Commercial U.S

2021

Jean Liu

Seattle Genetics

Chief Legal Officer

News

You may also like